THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Jan. 4, 2008--Amgen
(NASDAQ:AMGN) will participate in the 26th Annual JP Morgan Global
Healthcare Conference on Tuesday, Jan. 8, 2008, at the Westin St.
Francis in San Francisco, Calif., beginning at 7:30 a.m. Pacific Time.
Amgen Chairman and CEO Kevin Sharer will present at the conference.
Live audio of the presentation will be available over the Internet and
can be accessed from Amgen´s Web site, www.amgen.com, under Investors.
Information regarding presentation time, webcast availability, and
webcast links are available on Amgen´s Investor Relations Events
Amgen discovers, develops and delivers innovative human
therapeutics. A biotechnology pioneer since 1980, Amgen was one of the
first companies to realize the new science´s promise by bringing safe
and effective medicines from lab, to manufacturing plant, to patient.
Amgen therapeutics have changed the practice of medicine, helping
millions of people around the world in the fight against cancer,
kidney disease, rheumatoid arthritis, and other serious illnesses.
With a deep and broad pipeline of potential new medicines, Amgen
remains committed to advancing science to dramatically improve
people´s lives. To learn more about our pioneering science and our
vital medicines, visit www.amgen.com.
CONTACT: Amgen, Thousand Oaks
David Polk, 805-447-4613 or 805-490-0661 (media)
Cory Rivera, 805-447-1060 (investors)